A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 56.64% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -14.84%. Over the past 30 days, the price of SGMO has leaped by -18.95%. And in the last five days, it has fallen by -3.56%.
Sangamo Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.23 on 03/21/23, while the lowest value for the same period was recorded at $0.29 on 11/13/23.
52-week price history of SGMO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Sangamo Therapeutics Inc’s current trading price is -61.92% away from its 52-week high, while its distance from the 52-week low is 192.34%. The stock’s price range during this period has varied between$0.29 and $2.23. The Sangamo Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.08 million for the day, a figure considerably lower than their average daily volume of 2.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Sangamo Therapeutics Inc (SGMO) has experienced a quarterly rise of 97.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 152.25M and boasts a workforce of 405 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5881, with a change in price of +0.3647. Similarly, Sangamo Therapeutics Inc recorded 2,071,396 in trading volume during the last 100 days, posting a change of +74.99%.
SGMO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SGMO stands at 0.46. Similarly, the long-term debt-to-equity ratio is also 0.40.
SGMO Stock Stochastic Average
Sangamo Therapeutics Inc’s raw stochastic average for the past 50 days is presently 42.29%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 14.92%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.52% and 9.12%, respectively.
